Application Nr Approved Date Route Status External Links
ANDA075395 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Isosorbide Mononitrate Extended-Release Tablets Are Indicated For The Prevention Of Angina Pectoris Due To Coronary Artery Disease. The Onset Of Action Of Oral Ismn Is Not Sufficiently Rapid For This Product To Be Useful In Aborting An Acute Angina Episode.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Isosorbide Mononitrate

Comments